OrganOx was acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo in a deal valued at approximately £1.5 billion
14 July 2025
14 July 2025
Total investments received (USD): 173.57M
Related deals
Artios Pharma raised $115m in Series D funding co-led by SV Health Investors and RA Capital Management joined by Janus Henderson Investors and insiders.
Investments
07 November 2025
Belgium
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain